[1] |
Ganguly P, Alam SF. Role of homocysteine in the development of cardiovascular disease[J]. Nutr J, 2015, 14: 6.
|
[2] |
Kim J, Kim H, Roh H, et al. Causes of hyperhomocysteinemia and its pathological significance[J]. Arch Pharm Res, 2018, 41(4): 372-383.
|
[3] |
Blom HJ, Smulders Y. Overview of homocysteine and folate metabolism. With special references to cardiovascular disease and neural tube defects[J]. J Inherit Metab Dis, 2011, 34(1): 5-81.
|
[4] |
Esse R, Rocha MS, Barroso M, et al. Protein arginine methylation is more prone to inhibition by S-adenosylhomocysteine than DNA methylation in vascular endothelial cells[J]. PLoS One, 2013, 8(2): e55483.
|
[5] |
Pietrzik K, Bailey L, Shane B. Folic acid and L-5-methyltetrahydrofolate: comparison of clinical pharmacokinetics and pharmacodynamics[J]. Clin Pharmacokinet, 2010, 49(8): 535-548.
|
[6] |
Maron BA, Loscalzo J. The treatment of hyperhomocysteinemia[J]. Annu Rev Med, 2009, 60: 39-54.
|
[7] |
Qin X, Li J, Cui Y, et al. MTHFR C677T and MTR A2756G polymorphisms and the homocysteine lowering efficacy of different doses of folic acid in hypertensive Chinese adults[J]. Nutr J, 2012, 11: 2.
|
[8] |
Yakub M, Moti N, Parveen S, et al. Polymorphisms in MTHFR, MS and CBS genes and homocysteine levels in a pakistani population[J]. PLoS One, 2012, 7(3): e33222.
|
[9] |
Yakub M, Iqbal MP, Kakepoto GN, et al. High prevalence of mild hyperhomocysteinemia and folate, B12 and B6 deficiencies in an urban population in Karachi, Pakistan[J]. Pak J Med Sci, 2010, 26(4): 923-929.
|
[10] |
Kozyraki R, Cases O. Vitamin B12 absorption: mammalian physiology and acquired and inherited disorders[J]. Biochimie, 2013, 95(5): 1002-1007.
|
[11] |
Bamashmoos SA, Al-Nuzaily MA, Al-Meeri AM, et al. Relationship between total homocysteine, total cholesterol and creatinine levels in overt hypothyroid patients[J]. Springerplus, 2013, 2: 423.
|
[12] |
Cicone F, Santaguida MG, My G, et al. Hyperhomocysteinemia in acute iatrogenic hypothyroidism: the relevance of thyroid autoimmunity[J]. J Endocrinol Invest, 2018, 41(7): 831-837.
|
[13] |
Norouzi V, Seifi M, Fallah S, et al. Effect of oral contraceptive therapy on homocysteine and C-reactive protein levels in women: an observational study[J]. Anadolu Kardiyol Derg, 2011, 11(8): 698-702.
|
[14] |
Sreckovic B, Sreckovic VD, Soldatovic I, et al. Homocysteine is a marker for metabolic syndrome and atherosclerosis[J]. Diabetes Metab Syndr, 2017, 11(3): 179-182.
|
[15] |
Zhang D, Chen Y, Xie X, et al. Homocysteine activates vascular smooth muscle cells by DNA demethylation of platelet-derived growth factor in endothelial cells[J]. J Mol Cell Cardiol, 2012, 53(4): 487-496.
|
[16] |
Zhao J, Chen H, Liu N, et al. Role of hyperhomocysteinemia and hyperuricemia in pathogenesis of atherosclerosis[J]. J Stroke Cerebrovasc Dis, 2017, 26(12): 2695-2699.
|
[17] |
Iqbal NS, Wu Y, Hazen S, et al. Elevated plasma homocysteine identifies patients with chronic heart failure at increased cardiovascular risk[J]. J Card Fail, 2012, 18(8): S87.
|
[18] |
Fournier P, Fourcade J, Roncalli J, et al. Homocysteine in chronic heart failure[J]. Clin Lab, 2015, 61(9): 1137-1145.
|
[19] |
Huang P, Wang F, Sah BK, et al. Homocysteine and the risk of age-related macular degeneration: a systematic review and meta-analysis[J]. Sci Rep, 2015, 5: 10585.
|
[20] |
Ghosh S, Saha M, Das D. A study on plasma homocysteine level in age-related macular degeneration[J]. Nepal J Ophthalmol, 2013, 5: 195-200.
|
[21] |
Mohamed R, Sharma I, Ibrahim AS, et al. Hyperhomocysteinemia alters retinal endothelial cells barrier function and angiogenic potential via activation of oxidative stress[J]. Sci Rep, 2017, 7(1): 11952.
|
[22] |
Hooper C, De Souto Barreto P, Coley N, et al. Cross-sectional associations of total plasma homocysteine with cortical β-amyloid independently and as a function of omega 3 polyunsaturated fatty acid status in older adults at risk of dementia[J]. J Nutr Health Aging, 2017, 21(10): 1075-1080.
|
[23] |
Weekman EM, Woolums AE, Sudduth TL, et al. Hyperhomocysteinemia-induced gene expression changes in the cell types of the brain[J]. ASN Neuro, 2017, 9(6): 759091417742296.
|
[24] |
Martínez-Vega R, Garrido F, Partearroyo T, et al. Folic acid deficiency induces premature hearing loss through mechanisms involving cochlear oxidative stress and impairment of homocysteine metabolism[J]. FASEB J, 2015, 29(2): 418-432.
|
[25] |
Loprinzi PD, Brown K, Gilham B. Breaking news: high homocysteine levels may increase hearing loss[J]. Hear J, 2012, 65(7): 30-32.
|
[26] |
Kundu S, Munjal C, Tyagi N, et al. Folic acid improves inner ear vascularization in hyperhomocysteinemic mice[J]. Hear Res, 2012, 284(1-2): 42-51.
|
[27] |
Fasano T, Pertinhez TA, Tribi L, et al. Laboratory assessment of sudden sensorineural hearing loss: a case-control study[J]. Laryngoscope, 2017, 127(10): 2375-2381.
|
[28] |
Zhang D, Wen X, Wu W, et al. Elevated homocysteine level and folate deficiency associated with increased overall risk of carcinogenesis: meta-analysis of 83 case-control studies involving 35,758 individuals[J]. PLoS One, 2015, 10(5): e0123423.
|
[29] |
Wu X, Zou T, Cao N, et al. Plasma homocysteine levels and genetic polymorphisms in folate metablism are associated with breast cancer risk in chinese women[J]. Hered Cancer Clin Pract, 2014, 12(1): 2.
|
[30] |
Miller JW, Beresford SA, Neuhouser ML, et al. Homocysteine, cysteine, and risk of incident colorectal cancer in the women’s health initiative observational cohort[J]. Am J Clin Nutr, 2013, 97(4): 827-834.
|
[31] |
Keshteli AH, Baracos VE, Madsen KL. Hyperhomocysteinemia as a potential contributor of colorectal cancer development in inflammatory bowel diseases: a review[J]. World J Gastroenterol, 2015, 21(4): 1081-1090.
|